American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 272-284, August 2008

Timing of Renal Replacement Therapy Initiation in Acute Renal Failure: A Meta-analysis

  • Victor F. Seabra, MD

      Affiliations

    • Division of Nephrology, Hospital das Clinicas, University of São Paulo, São Paulo, Brazil
  • ,
  • Ethan M. Balk, MD, MPH

      Affiliations

    • Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
  • ,
  • Orfeas Liangos, MD

      Affiliations

    • Department of Medicine, Caritas St Elizabeth's Medical Center, Boston, MA
  • ,
  • Marie Anne Sosa, MD

      Affiliations

    • Department of Medicine, Caritas St Elizabeth's Medical Center, Boston, MA
  • ,
  • Miguel Cendoroglo, MD

      Affiliations

    • Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil.
  • ,
  • Bertrand L. Jaber, MD, MS

      Affiliations

    • Department of Medicine, Caritas St Elizabeth's Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Bertrand L. Jaber, MD, MS, Department of Medicine, Caritas St Elizabeth's Medical Center, 736 Cambridge St, Boston, MA 02135.

Received 24 October 2007; accepted 28 February 2008. published online 19 June 2008.

Background

Some studies have suggested that early institution of renal replacement therapy (RRT) might be associated with improved outcomes in patients with acute renal failure (ARF).

Study Design

A systematic review and meta-analysis of randomized controlled trials and cohort comparative studies to assess the effect of early RRT on mortality in patients with ARF.

Setting & Population

Hospitalized adult patients with ARF.

Selection Criteria for Studies

We searched several databases for studies that compared the effect of “early” and “late” RRT initiation on mortality in patients with ARF. We included studies of various designs.

Intervention

Early RRT as defined in the individual studies.

Outcomes

The primary outcome measure was the effect of early RRT on mortality stratified by study design. The pooled risk ratio (RR) for mortality was compiled using a random-effects model. Heterogeneity was evaluated by means of subgroup analysis and meta-regression.

Results

We identified 23 studies (5 randomized or quasi-randomized controlled trials, 1 prospective and 16 retrospective comparative cohort studies, and 1 single-arm study with a historic control group). By using meta-analysis of randomized trials, early RRT was associated with a nonsignificant 36% mortality risk reduction (RR, 0.64; 95% confidence interval, 0.40 to 1.05; P = 0.08). Conversely, in cohort studies, early RRT was associated with a statistically significant 28% mortality risk reduction (RR, 0.72; 95% confidence interval, 0.64 to 0.82; P < 0.001). The overall test for heterogeneity among cohort studies was significant (P = 0.005). Meta-regression yielded no significant associations; however, early dialysis therapy was associated more strongly with lower mortality in smaller studies (n < 100) by means of subgroup analysis.

Limitations

Paucity of randomized controlled trials, use of variable definitions of early RRT, and publication bias preclude definitive conclusions.

Conclusion

This hypothesis-generating meta-analysis suggests that early initiation of RRT in patients with ARF might be associated with improved survival, calling for an adequately powered randomized controlled trial to address this question.

Index Words: Acute renal failure, ARF, dialysis, hemodialysis, continuous renal replacement therapy, timing, prophylactic, early, late, intensive, mortality, meta-analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2008.02.371 on June 19, 2008.Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Jonathan Craig, MD, PhD, University of Sydney) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(08)00829-9

doi:10.1053/j.ajkd.2008.02.371

American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 272-284, August 2008